Skip to main content
Year archive

OXFORD BIODYNAMICS PLC — 2018 filings

All 40 regulatory filings released by OXFORD BIODYNAMICS PLC (OBD) in 2018, sourced directly from the official regulator.

40 Filings
2018 Period
2018 filings (40)
Filing Released Lang
Final Results
Earnings Release FY 2018
2018-12-11 English
Total Voting Rights
Regulatory Filings
2018-12-03 English
Notice of results for year ended 30 Sept 2018
Report Publication Announcement
2018-11-23 English
Collaboration into identifying diagnosis of Autism
Regulatory Filings
2018-11-12 English
OBD signs fifth collaboration agreement
M&A Activity
2018-11-08 English
Study published in Faculty of 1000 Research
Regulatory Filings
2018-11-07 English
Issue of Equity
Declaration of Voting Results & Voting Rights Announcements
2018-11-06 English
Total Voting Rights
Regulatory Filings
2018-11-01 English
Issue of Equity
Regulatory Filings
2018-10-02 English
Issue of Equity
Regulatory Filings
2018-09-26 English
Consortium with OBD receives ?4m Horizon 2020 fund
Regulatory Filings
2018-09-18 English
Total Voting Rights
Regulatory Filings
2018-09-04 English
Holding(s) in Company
Major Shareholding Notification
2018-08-30 English
Holding(s) in Company
Major Shareholding Notification
2018-08-29 English
Holding(s) in Company
Major Shareholding Notification
2018-08-29 English
Holding(s) in Company
Major Shareholding Notification
2018-08-29 English
Holding(s) in Company
Major Shareholding Notification
2018-08-29 English
Holding(s) in Company
Major Shareholding Notification
2018-08-29 English
Chinese Investment Group Takes Stake in OBD
Share Issue/Capital Change
2018-08-22 English
Grant of Canadian patent for EpiSwitch platform
Regulatory Filings
2018-07-19 English
OBD presents latest EpiSwitch data at ASH Summit
Regulatory Filings
2018-07-17 English
Total Voting Rights
Regulatory Filings
2018-07-02 English
ALS study published in peer reviewed journal
Regulatory Filings
2018-06-26 English
Issue of Equity
Regulatory Filings
2018-06-19 English
Interim Results for the Period Ended 31 March 2018
Interim / Quarterly Report H1 2018
2018-05-22 English
Total Voting Rights
Regulatory Filings
2018-05-01 English
Notice of Interim Results
Report Publication Announcement
2018-04-17 English
Publication in Journal of Translational Medicine
Regulatory Filings
2018-03-28 English
PDMR Dealing/Grant of Share Options
Director's Dealing
2018-03-19 English
ALS biomarker data presented at World CNS Summit
Regulatory Filings
2018-03-16 English
Results of Annual General Meeting
AGM Information
2018-03-15 English
Publication of Annual Report and Notice of AGM
Regulatory Filings
2018-02-15 English
Grant of Indian patent for EpiSwitch platform
Regulatory Filings
2018-02-14 English
Shore Capital appointed as NOMAD and Sole Broker
Regulatory Filings
2018-01-30 English
Final Results for the Year Ended 30 September 2017
Earnings Release FY 2017
2018-01-30 English
Collaboration in sports-related concussions
Environmental & Social Information
2018-01-29 English
Notice of Results
Report Publication Announcement
2018-01-16 English
Holding(s) in Company
Regulatory Filings
2018-01-05 English
Signs 2nd agreement with US biopharma company
Regulatory Filings
2018-01-03 English
Total Voting Rights
Regulatory Filings
2018-01-02 English